Q92993 (KAT5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 143.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Histone acetyltransferase KAT5 EC=2.3.1.48 Alternative name(s): 60 kDa Tat-interactive protein Short name=Tip60 Histone acetyltransferase HTATIP Short name=HIV-1 Tat interactive protein Lysine acetyltransferase 5 cPLA(2)-interacting protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 513 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Directly acetylates and activates ATM. In case of HIV-1 infection, interaction with the viral Tat protein leads to KAT5 polyubiquitination and targets it to degradation. Ref.14 Ref.18 Ref.20 Ref.21 Ref.22 Ref.24 Ref.26 Ref.30 |
| Catalytic activity | Acetyl-CoA + [histone] = CoA + acetyl-[histone]. Ref.10 |
| Subunit structure | Interacts with the cytoplasmic tail of APP and APBB1/FE65 By similarity. Interacts with PLA2G4A/CPLA2, EDNRA and HDAC7. Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. HTATTIP/TIP60, EPC1, and ING3 together constitute a minimal HAT complex termed Piccolo NuA4. The NuA4 complex interacts with MYC and the adenovirus E1A protein. Interacts with ATM. Interacts with PHF17. Interacts with HIV-1 Tat. Interacts with TRIM24 and TRIM68. Forms a complex with SENP6 and UBE2I in response to UV irradiation. Identified in a complex with HINT1. Ref.1 Ref.2 Ref.9 Ref.11 Ref.12 Ref.16 Ref.19 Ref.20 Ref.23 Ref.24 Ref.25 Ref.27 Ref.30 |
| Subcellular location | Nucleus › nucleolus. Cytoplasm › perinuclear region. Note: Upon stimulation with EDN1, it is exported from the nucleus to the perinuclear region and UV irradiation induces translocation into punctuate subnuclear structures named nuclear bodies. Ref.2 Ref.16 Ref.26 Ref.28 |
| Post-translational modification | Sumoylated by UBE2I at Lys-430 and Lys-451, leading to increase of its histone acetyltransferase activity in UV-induced DNA damage response, as well as its translocation to nuclear bodies. Ref.28 Phosphorylated on Ser-86 and Ser-90; enhanced during G2/M phase. Phosphorylated form has a higher activity. Ref.15 Ubiquitinated by MDM2, leading to its proteasome-dependent degradation. Ref.13 Autoacetylation at Lys-327 is required for proper function By similarity. |
| Sequence similarities | Belongs to the MYST (SAS/MOZ) family. Contains 1 C2HC-type zinc finger. |
| Sequence caution | The sequence AAB02683.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ATXN1 | P54253 | 3 | EBI-399080,EBI-930964 | |
| CBX8 | Q9HC52 | 2 | EBI-399080,EBI-712912 | |
| DLEU1 | O43261 | 2 | EBI-399080,EBI-710057 | |
| GADD45G | O95257 | 2 | EBI-399080,EBI-448202 | |
| KIAA1377 | Q9P2H0 | 2 | EBI-399080,EBI-473176 | |
| PTPN4 | P29074 | 2 | EBI-399080,EBI-710431 | |
| TP53 | P04637 | 3 | EBI-399080,EBI-366083 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q92993-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q92993-2) Also known as: PLIP; The sequence of this isoform differs from the canonical sequence as follows: 96-147: Missing. | ||||||
| Isoform 3 (identifier: Q92993-3) The sequence of this isoform differs from the canonical sequence as follows: 4-4: V → VVSPVPGAGRREPGEVGRARGPPVADPGVALSPQ | ||||||
| Isoform 4 (identifier: Q92993-4) The sequence of this isoform differs from the canonical sequence as follows: 4-4: V → VVSPVPGAGRREPGEVGRARGPPVADPGVALSPQ 96-147: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 513 | 513 | Histone acetyltransferase KAT5 | PRO_0000051580 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Zinc finger | 261 – 283 | 23 | C2HC-type | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 377 – 383 | 7 | Acetyl-CoA binding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 327 | 1 | By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 369 | 1 | Nucleophile By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 372 | 1 | Acetyl-CoA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 407 | 1 | Acetyl-CoA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 52 | 1 | N6-acetyllysine Ref.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 86 | 1 | Phosphoserine Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 90 | 1 | Phosphoserine; by CDK1 Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 327 | 1 | N6-acetyllysine; by autocatalysis By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 430 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 451 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 4 | 1 | V → VVSPVPGAGRREPGEVGRAR GPPVADPGVALSPQ in isoform 3 and isoform 4. | VSP_009104 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 96 – 147 | 52 | Missing in isoform 2 and isoform 4. | VSP_007438 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 78 | 1 | P → T. Corresponds to variant rs11541271 [ dbSNP | Ensembl ]. | VAR_059456 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 86 | 1 | S → A: Reduces phosphorylation. Abolishes phosphorylation; when associated with A-90. Reduced activity. Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 90 | 1 | S → A: Reduces phosphorylation. Abolishes phosphorylation; when associated with A-86. Reduced activity. Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 254 | 1 | L → A: Does not affect phosphorylation; when associated with A-257. Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 257 | 1 | L → A: Does not affect phosphorylation; when associated with A-254. Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 380 | 1 | G → A: Loss of function. Does not affect phosphorylation. Ref.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 430 | 1 | K → R: Abrogates sumoylation. Ref.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 451 | 1 | K → R: Abrogates sumoylation. Ref.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 382 | 1 | G → R in AAB18236. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 382 | 1 | G → R in AAB02683. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Isoform 3: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 32 | 1 | V → A no nucleotide entry Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 12 – 15 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 28 – 34 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 37 – 39 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 43 – 47 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 58 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 60 – 62 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 65 – 67 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 235 – 237 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 240 – 242 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 252 – 254 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 260 – 262 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 264 – 266 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 269 – 271 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 273 – 282 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 289 – 296 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 299 – 305 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 306 – 308 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 310 – 321 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 328 – 331 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 336 – 345 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 348 – 360 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 365 – 368 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 370 – 372 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 374 – 376 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 381 – 395 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 400 – 402 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 408 – 425 | 18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 441 – 448 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 452 – 461 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 469 – 474 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 497 – 499 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator." Kamine J., Elangovan B., Subramanian T., Coleman D., Chinnadurai G. Virology 216:357-366(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH HIV-1 TAT. Tissue: Lymphoblast. |
| [2] | "PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production." Sheridan A.M., Force T., Yoon H.J., O'Leary E., Choukroun G., Taheri M.R., Bonventre J.V. Mol. Cell. Biol. 21:4470-4481(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH PLA2G4A, SUBCELLULAR LOCATION. Tissue: Fibroblast and Placenta. |
| [3] | "Identification of a larger form of the histone acetyl transferase Tip60." Legube G., Trouche D. Gene 310:161-168(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [4] | NIEHS SNPs program Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Uterus. |
| [6] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Cervix, Liver, Placenta and Testis. |
| [9] | "Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex." Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J., Conaway R.C., Conaway J.W. J. Biol. Chem. 278:42733-42736(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 19-35; 150-177 AND 297-307, IDENTIFICATION IN NUA4 COMPLEX, MASS SPECTROMETRY. |
| [10] | "Tip60 acetylates six lysines of a specific class in core histones in vitro." Kimura A., Horikoshi M. Genes Cells 3:789-800(1998) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME ACTIVITY IN VITRO. |
| [11] | "Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis." Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., Nakatani Y. Cell 102:463-473(2000) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE NUA4 COMPLEX, MASS SPECTROMETRY. |
| [12] | "Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling." Lee H.-J., Chun M., Kandror K.V. J. Biol. Chem. 276:16597-16600(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EDNRA. |
| [13] | "Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation." Legube G., Linares L.K., Lemercier C., Scheffner M., Khochbin S., Trouche D. EMBO J. 21:1704-1712(2002) [PubMed] [Europe PMC] [Abstract] Cited for: UBIQUITINATION. |
| [14] | "MYC recruits the TIP60 histone acetyltransferase complex to chromatin." Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M., Livingston D.M., Amati B. EMBO Rep. 4:575-580(2003) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE IN MYC-DEPENDENT TRANSCRIPTION. |
| [15] | "Tip60 acetyltransferase activity is controlled by phosphorylation." Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D., Khochbin S. J. Biol. Chem. 278:4713-4718(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-86 AND SER-90, MUTAGENESIS OF SER-86; SER-90; LEU-254; LEU-257 AND GLY-380. |
| [16] | "Tip60 is a co-repressor for STAT3." Xiao H., Chung J., Kao H.-Y., Yang Y.-C. J. Biol. Chem. 278:11197-11204(2003) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION WITH HDAC7. |
| [17] | "The highly conserved and multifunctional NuA4 HAT complex." Doyon Y., Cote J. Curr. Opin. Genet. Dev. 14:147-154(2004) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON NUA4 COMPLEX. |
| [18] | "Role of the histone acetyl transferase Tip60 in the p53 pathway." Legube G., Linares L.K., Tyteca S., Caron C., Scheffner M., Chevillard-Briet M., Trouche D. J. Biol. Chem. 279:44825-44833(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE IN TP53-DEPENDENT TRANSCRIPTION. |
| [19] | "von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity." Panchenko M.V., Zhou M.I., Cohen H.T. J. Biol. Chem. 279:56032-56041(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PHF17. |
| [20] | "Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans." Doyon Y., Selleck W., Lane W.S., Tan S., Cote J. Mol. Cell. Biol. 24:1884-1896(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE NUA4 COMPLEX. |
| [21] | "E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1." Taubert S., Gorrini C., Frank S.R., Parisi T., Fuchs M., Chan H.M., Livingston D.M., Amati B. Mol. Cell. Biol. 24:4546-4556(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE IN E2F1-DEPENDENT TRANSCRIPTION. |
| [22] | "A large-scale RNAi screen in human cells identifies new components of the p53 pathway." Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L., Bernards R. Nature 428:431-437(2004) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE IN TP53-DEPENDENT TRANSCRIPTION. |
| [23] | "HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses." Col E., Caron C., Chable-Bessia C., Legube G., Gazzeri S., Komatsu Y., Yoshida M., Benkirane M., Trouche D., Khochbin S. EMBO J. 24:2634-2645(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HIV-1 TAT. |
| [24] | "A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM." Sun Y., Jiang X., Chen S., Fernandes N., Price B.D. Proc. Natl. Acad. Sci. U.S.A. 102:13182-13187(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ATM, FUNCTION. |
| [25] | "The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity." Weiske J., Huber O. J. Biol. Chem. 281:27356-27366(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH HINT1. |
| [26] | "ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation." Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W., Lane W.S., Tan S., Yang X.-J., Cote J. Mol. Cell 21:51-64(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [27] | "TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells." Miyajima N., Maruyama S., Bohgaki M., Kano S., Shigemura M., Shinohara N., Nonomura K., Hatakeyama S. Cancer Res. 68:3486-3494(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRIM68. |
| [28] | "Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response." Cheng Z., Ke Y., Ding X., Wang F., Wang H., Wang W., Ahmed K., Liu Z., Xu Y., Aikhionbare F., Yan H., Liu J., Xue Y., Yu J., Powell M., Liang S., Wu Q., Reddy S.E. Yao X.Oncogene 27:931-941(2008) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-430 AND LYS-451, MUTAGENESIS OF LYS-430 AND LYS-451, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION OF KAT5-UBE2I-SENP6 COMPLEX. |
| [29] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [30] | "TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells." Kikuchi M., Okumura F., Tsukiyama T., Watanabe M., Miyajima N., Tanaka J., Imamura M., Hatakeyama S. Biochim. Biophys. Acta 1793:1828-1836(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH TRIM24. |
| [31] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Leukemic T-cell. |
| [32] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, MASS SPECTROMETRY. |
| [33] | "The crystal structure of acetyltransferase domain of human HIV-1 TAT interacting protein in complex with acetylcoenzyme A." Structural genomics consortium (SGC) Submitted (FEB-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 227-506 IN COMPLEX WITH ACETYL COENZYME A AND ZINC IONS. |
| [34] | "Solution structure of RUH-073, a pseudo chromo domain from human cDNA." RIKEN structural genomics initiative (RSGI) Submitted (FEB-2009) to the PDB data bank Cited for: STRUCTURE BY NMR OF 5-78. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U74667 mRNA. Translation: AAB18236.1. U40989 mRNA. Translation: AAB02683.1. Different initiation. U67734 mRNA. Translation: AAD00163.1. AY214165 Genomic DNA. Translation: AAO21130.1. AK304664 mRNA. Translation: BAG65439.1. AP001266 Genomic DNA. No translation available. CH471076 Genomic DNA. Translation: EAW74427.1. CH471076 Genomic DNA. Translation: EAW74429.1. BC000166 mRNA. Translation: AAH00166.3. BC064912 mRNA. Translation: AAH64912.1. BC093032 mRNA. Translation: AAH93032.1. BC143296 mRNA. Translation: AAI43297.1. BC117167 mRNA. Translation: AAI17168.1. | ||||||||||||||||||
| IPI | IPI00165536. IPI00290020. IPI00394657. IPI00981546. | ||||||||||||||||||
| RefSeq | NP_001193762.1. NM_001206833.1. NP_006379.2. NM_006388.3. NP_874368.1. NM_182709.2. NP_874369.1. NM_182710.2. | ||||||||||||||||||
| UniGene | Hs.397010. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q92993. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP-5998N. | ||||||||||||||||||
| IntAct | Q92993. 59 interactions. | ||||||||||||||||||
| MINT | MINT-94861. | ||||||||||||||||||
| STRING | 9606.ENSP00000340330. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q92993. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 30923328. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q92993. | ||||||||||||||||||
| PRIDE | Q92993. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 10524. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000341318; ENSP00000340330; ENSG00000172977. ENST00000352980; ENSP00000344955; ENSG00000172977. ENST00000377046; ENSP00000366245; ENSG00000172977. ENST00000530446; ENSP00000434765; ENSG00000172977. | ||||||||||||||||||
| GeneID | 10524. | ||||||||||||||||||
| KEGG | hsa:10524. | ||||||||||||||||||
| UCSC | uc001ofi.3. human. uc001ofj.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 10524. | ||||||||||||||||||
| GeneCards | GC11P065479. | ||||||||||||||||||
| HGNC | HGNC:5275. KAT5. | ||||||||||||||||||
| HPA | HPA016953. | ||||||||||||||||||
| MIM | 601409. gene. | ||||||||||||||||||
| neXtProt | NX_Q92993. | ||||||||||||||||||
| PharmGKB | PA162392746. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG5027. | ||||||||||||||||||
| HOGENOM | HOG000182457. | ||||||||||||||||||
| KO | K11304. | ||||||||||||||||||
| OMA | HDDIITR. | ||||||||||||||||||
| OrthoDB | EOG4JHCFH. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | ar_tf_pathway. Regulation of Androgen receptor activity. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q92993. | ||||||||||||||||||
| Bgee | Q92993. | ||||||||||||||||||
| CleanEx | HS_KAT5. | ||||||||||||||||||
| Genevestigator | Q92993. | ||||||||||||||||||
| GermOnline | ENSG00000172977. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 3.40.630.30. 1 hit. | ||||||||||||||||||
| InterPro | IPR016181. Acyl_CoA_acyltransferase. IPR000953. Chromo_domain/shadow. IPR016197. Chromodomain-like. IPR002717. MOZ_SAS. IPR025995. Tudor-knot. [Graphical view] | ||||||||||||||||||
| Pfam | PF01853. MOZ_SAS. 1 hit. PF11717. Tudor-knot. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00298. CHROMO. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF55729. Acyl_CoA_acyltransferase. 1 hit. SSF54160. Chromodomain-like. 1 hit. | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | Q92993. | ||||||||||||||||||
| ChEMBL | CHEMBL5750. | ||||||||||||||||||
| EvolutionaryTrace | Q92993. | ||||||||||||||||||
| GenomeRNAi | 10524. | ||||||||||||||||||
| NextBio | 39922. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | KAT5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92993 Secondary accession number(s): B4E3C7 Q9BWK7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
